What Is Hypoxia and Why It Matters in Device Validation   Hypoxia refers to a reduction in oxygen availability at the tissue level. In clinical research and pulse oximetry validation, the focus is arterial oxygen saturation (SaO₂) or the percentage of hemoglobin molecules carrying oxygen in the blood.  The Parameters Research Laboratory (PRL) Hypoxia Lab in Broomfield, Colorado is designed for pulse oximetry validation. By safely simulating altitude and lowering oxygen levels

Understanding the Fundamentals Behind Accurate SpO₂ Measurement   Pulse oximetry is deceptively simple on the surface: shine light into tissue, measure what comes back, and estimate oxygen saturation. In practice, pulse oximeter design involves a series of tightly coupled optical, physiological, and signal-processing decisions that directly influence performance, inclusivity, and regulatory readiness.  For device developers, understanding these fundamentals early can reduce d

As wearable and software-enabled technologies increasingly estimate physiological parameters such as oxygen saturation, blood pressure, and heart rate variability, regulatory classification has become a critical design consideration. The FDA’s General Wellness: Policy for Low Risk Devices clarifies when products using non-invasive sensing—such as optical sensing—may be considered general wellness products rather than regulated medical devices.  For developers conducting a cl

Physiological monitoring in wearables has expanded rapidly, but blood pressure and heart-rate sensing now represent two of the most scrutinized technologies for regulators. As devices transition from lifestyle tools to clinical-grade solutions, development teams must demonstrate performance that meets rigorous standards such as ISO 81060-2 , ISO 81060-7, ISO 81060-3 and ISO 14155 .  Parameters Research Laboratory (PRL) supports developers navigating this shift by delivering

Pulse oximetry is broadly adopted across clinical care and wearable technologies. Standardized terminology shared by engineering, clinical research, and regulatory teams promotes aligned protocols, reproducible analyses, and more efficient FDA and CE reviews.   This glossary provides clear definitions of core pulse oximetry terms commonly encountered during pulse oximetry testing, controlled desaturation studies following ISO 80601-2-61 , and regulatory-grade CRO engagements.

A Familiar Framework with Important Regulatory Implications   In January 2026, the FDA released a draft guidance titled “ Cuffless Non-Invasive Blood Pressure Measuring Devices – Clinical Performance Testing and Evaluation .” The document outlines FDA’s current recommendations on how cuffless blood pressure (BP) devices—both intermittent and continuous—should be clinically evaluated to support premarket submissions.  For developers already working in this space, the guidance

Dyshemoglobins and Pulse Oximetry: How COHb and MetHb Influence Measurement Accuracy   Pulse oximetry has become central to physiological monitoring across wearables, medical devices, and clinical research studies. Yet even the most advanced sensor architectures face fundamental challenges when hemoglobin exists in altered forms—known as dyshemoglobins . Carboxyhemoglobin (COHb) and methemoglobin (MetHb) change light absorption in ways that directly influence SpO₂ readings an

When planning a clinical research study intended to support an FDA submission , sponsors often encounter terms such as multi-site, multi-investigator , and single-site, multiple-location . While these models may appear operationally similar, they differ in oversight structure, execution, and how evidence is evaluated by the FDA—particularly for cuffless blood pressure devices . Understanding these distinctions is essential for aligning trial design with FDA expectations and w

Accurate oxygen saturation measurement is foundational for modern physiological monitoring, especially for developers of pulse oximeters, wearables, and multiparameter platforms. Yet many devices fail to achieve regulatory expectations because their performance is never tested across the full range of oxygen saturation levels humans experience.  Controlled desaturation studies fill this gap, ensuring claims reflect real-world performance. These studies intentionally and safel

Engineering Reliability: What CTOs Need to Know About Regulatory-Grade Physiological Monitoring Validation   CTOs in medical-device startups face an engineering challenge that extends far beyond hardware and firmware. The success of a physiological monitoring product—whether a pulse oximeter, blood pressure monitor, or wearable sensing platform—depends on rigorous clinical research studies capable of supporting FDA and CE mark submissions. The gap between early engineering va

Introduction: Why Respiratory Rate Matters in Physiological Monitoring   Respiratory rate (RR) is a vital indicator of physiological stability—often the first parameter to shift in response to metabolic stress, infection, or hypoxia. Yet, continuous and unobtrusive respiratory monitoring remains challenging outside of controlled environments.  With the rise of wearable and optical sensing technologies, electrocardiography (ECG) and photoplethysmography (PPG) have emerged as

Introduction: The Importance of Clarity in Blood Pressure Device and Software Classification   As wearable technology advances, more devices are integrating blood pressure features—from clinical-grade monitors to smartwatches that “notify” users of potential changes. But not all blood pressure devices are created—or regulated—the same.  Understanding the difference between a blood pressure measurement device (FDA product code DXN) and a hypertension machine learning-based no

In clinical research for medical devices and wearable technologies, data quality is everything . Regulatory clearance depends not just on whether a study was conducted, but on whether the data generated is regulator-ready, reproducible, and scientifically defensible . Yet not all Service Providers (formally known as Clinical Research Organizations (CROs)) bring the same level of expertise, infrastructure, or dedicated staff to ensure that outcome.  Sponsors sometimes face a d

On September 16, 2025, the FDA issued a safety communication  warning consumers and healthcare providers about the risks of using...

At Parameters Research Laboratory (PRL) , we specialize in providing regulatory-grade validation for blood pressure monitoring devices,...

Developing and validating physiological monitoring devices requires more than engineering excellence. The reliability of study...

When developing a new medical device or wearable technology, navigating the FDA regulatory pathway can be complex and resource-intensive....

Why Arterial Line Monitoring Matters in Research   When evaluating new medical devices—particularly those designed for physiological...

Why the Participant Experience Matters to Sponsors   For sponsors developing wearable medical devices, every detail of a clinical...

Introduction   Cuffless blood pressure (BP) monitoring has become a major focus in wearable and medical device innovation. Unlike...